Starbucks Corporation (SBUX)
Mexican Exchange · Mexico · prices in MXN · close of 22 Oct 2026
Key indicators
| Last close | MXN 1,896.99 |
|---|---|
| 52-week range | 1,460.00 – 1,899.50 |
| Return, 1 month / 3 months | +15.7% / +5.2% |
| Return, 1 year / 3 years | +23.7% / +18.5% |
| Trend | Uptrend |
| RSI (14) | 72 |
| Volatility (1 year) | 29.6% |
| Worst drawdown (1 year) | -13.1% |
| Average daily value traded | 0.28M MXN |
| Dividend yield | 2.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Starbucks Corporation runs a chain of coffeehouses where customers buy coffee, espresso drinks, teas, cold beverages, pastries and light food. The company also sells packaged coffee and related goods through retail and other channels. Its coffeehouses serve individual consumers in cities and towns across many countries, and the business is based in Seattle in the United States. Starbucks operates both company-run and licensed stores in markets around the world.
On this site Starbucks Corporation appears as a stock on the Mexican Exchange (Mexico), code SBUX, with prices in Mexican pesos (MXN). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Starbucks Corporation (SBUX) trades on the Mexican Exchange in Mexico. It last closed at MXN 1,896.99 on 22 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 94 of 361 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 23.7% and over the last three months it rose 5.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Mexican Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 10.0% | ||
| From 52-week high | 0.0% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 5.2% | ||
| 6-month return | 11.2% | ||
| 12-month return, skipping the last month | 7.0% | ||
| Stability (higher is calmer) | 66 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.1% | ||
| Liquidity | 39 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.28M MXN | ||
| Zero-volume days | 16.7% | ||
| Income | 65 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.3% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +7.5% |
|---|---|
| 1 month | +15.7% |
| 3 months | +5.2% |
| 6 months | +11.2% |
| 1 year | +23.7% |
| 3 years | +18.5% |
| 5 years | −7.4% |
Signals
| 50-day / 200-day average | 1,748.43 / 1,724.77 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 31.92 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Aug 2026 | MXN 10.5403 |
| 15 May 2026 | MXN 10.7573 |
| 13 Feb 2026 | MXN 10.6553 |
| 14 Nov 2025 | MXN 11.3522 |
| 15 Aug 2025 | MXN 11.3997 |
| 16 May 2025 | MXN 11.9273 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Mexican Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.